Fresenius Kabi Contract Manufacturing
- Biotech or pharma, therapeutic R&D
- CMO, CRO
Caring for the critically ill Patient in the Hospital
Fresenius Kabi employs over 43,000 people worldwide. In 2023 the company reported sales of more than €8 billion. Fresenius Kabi AG is a wholly owned subsidiary of the Fresenius SE & Co. KGaA.
)
)
){kind=logo}
){kind=logo}
){kind=logo}